Evidence map›Paper›PMID 28190092›Full record

SynthesisInternational orthopaedics2017

Proliferative injection therapy for osteoarthritis: a systematic review.

Mišo Krstičević, Milka Jerić, Svjetlana Došenović, Antonia Jeličić Kadić, Livia Puljak

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in International orthopaedics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mišo KrstičevićDepartment of Orthopedics, University Hospital Split, Split, Croatia.
Milka JerićDepartment of Dermatovenerology, General Hospital Zadar, Zadar, Croatia.
Svjetlana DošenovićDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Split, Split, Croatia.
Antonia Jeličić KadićLaboratory for Pain Research, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia.
Livia PuljakLaboratory for Pain Research, University of Split School of Medicine, Šoltanska 2, 21000, Split, Croatia. livia@mefst.hr.
University of Split · HRUniversity of Zadar · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo systematically analyse randomised controlled trials (RCTs) about efficacy and safety of proliferative injection therapy (prolotherapy) for treatment of osteoarthritis (OA).

methodsCENTRAL, Embase and MEDLINE were searched. Two reviewers independently conducted screening and data extraction. RCTs were assessed with the Cochrane risk of bias tool. Type of treatment, study design, dosing, efficacy outcomes and safety outcomes were analysed. The protocol was registered in PROSPERO (CRD42016035258).

resultsSeven RCTs were included, with 393 participants aged 40-75 years and mean OA pain duration from three months to eight years. Follow-up was 12 weeks to 12 months. Studies analysed OA of the knee joint (n = 5), first carpometacarpal joint (n = 1) and finger joints (n = 1). Various types of prolotherapy were used; dextrose was the most commonly used irritant agent. All studies concluded that prolotherapy was effective treatment for OA. No serious adverse events were reported. The studies had considerable methodological limitations. DISCUSSION: Limited evidence from low-quality studies indicates a beneficial effect of prolotherapy for OA management. The number of participants in these studies was too small to provide reliable evidence.

conclusionsCurrent data from trials about prolotherapy for OA should be considered preliminary, and future high-quality trials on this topic are warranted.

Indexed as

AdultAgedHumansMaleMiddle AgedOsteoarthritisPainPain ManagementProlotherapyDextroseOsteoarthritisPainProliferative injection therapyProlotherapy

Identifiers

PMID28190092
OpenAlexW2587063944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.